RELB is emerging as an important player in various non-leukaemic cancers, including those dependent upon RAS signalling26, 36, 37, yet has unclear functions or transcriptional targets in non-haematopoietic lineages35, 38, 39. The gene discussed is RELB; the disease is cancer.